Balaji Amines Ltd
Balaji Amines Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.
Based on Balaji Amines Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Revenue from Operations for Q1 FY27: Rs. EBITDA for Q1 FY27: Rs.
From Balaji Amines Ltd's Q1 FY27 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Revenue from Operations for Q1 FY27: Rs. 456 Cr (vs Rs. 358 Cr in Q1 FY26), a 27% year-on-year increase.
- Total Revenue for Q1 FY27: Rs. 461 Cr (vs Rs. 367 Cr in Q1 FY26), up 25.7% year-on-year.
- Volume Growth Outlook: FY27 volume growth guided at 10-15%, with a medium-term growth target of 20-30%.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Balaji Amines Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- ₹1000 Cr+ expansion cycle nearing completion on consolidated basis (Page 14)
- Capital work-in-progress of Rs. 401.06 Cr at BSCL for:
- Greenfield expansion to manufacture HCN, NaCN, EDTA, EDTA-Na, and other advanced chemicals
- Brownfield expansions for EDA-based chemical production (Page 28)
- Upcoming projects:
- HCN, Sodium Cyanide, EDTA & EDTA-2Na greenfield project, commissioning targeted by end FY27 (Page 13)
- EDA derivatives project (DETA, TETA, PIP, AEEA & AEP), commissioning targeted during FY27 (Page 13)
- NMM (N-Methyl Morpholine) plant expansion: 5,000 TPA proposed, expected commissioning by FY27 (Pages 14, 12)
- Acetonitrile (ACN) expansion: 9,000 TPA proposed additional capacity, commissioning expected in FY27 (Pages 14, 12)
- DME plant: 100,000 TPA, India's first commercial-scale, successfully commissioned in Q1 FY27 (Page 12)
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Balaji Amines Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Balaji Amines Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹395 Cr, net profit ₹65 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Balaji Amines Ltd's management said in earlier quarters
- Q3 FY24 earnings call analysis →
- Q1 FY25 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q4 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
- Q4 FY22 earnings call →
- Q3 FY22 earnings call →
Others in Chemicals & Petrochemicals this season
- Prasol Chemicals Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹433.6 crores . Key investor presentation takeaways from Prasol Chemicals Ltd's Q1 FY27 investor presentation — and how it rank
- Vipul Organics Ltd (Q1 FY27)
Q1 FY27 net revenue: ₹51.78 crore, up +37.7% YoY (Page 13) . Key concall takeaways from Vipul Organics's Q1 FY27 earnings call — and how it ranks against…
- Fine Organic Industries Ltd (Q1 FY27)
Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…
- Chemfab Alkalis Ltd (Q1 FY27)
Consolidated Q1FY27 Revenue from Operations:** ₹73.16 crore, down 20.08% YoY (from ₹91.54 crore in Q1FY26). Key concall takeaways from Chemfab Alkalis Ltd's Q1…
Frequently Asked Questions
What were Balaji Amines Ltd Q1 FY27 results?
Revenue from Operations for Q1 FY27: Rs. EBITDA for Q1 FY27: Rs.
What is Balaji Amines Ltd share price analysis?
Balaji Amines Ltd currently shows a neutral. The stock trades at a P/E of 34.5 with a market cap of ₹7,036 Cr. Investors should review the full earnings analysis for detailed insights.
Is Balaji Amines Ltd planning capital expenditure?
₹1000 Cr+ expansion cycle nearing completion on consolidated basis (Page 14) - Capital work-in-progress of Rs.
Keep Balaji Amines Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.